DIRS.INFO The most relevant business & tech news

☆ What you need to know about Kamala Harris' 'opportunity economy'
▼ + stars: | 2024-09-11 | by ( Kwan Wei Kevin Tan | Joshua Nelken-Zitser | ) www.businessinsider.com time to read: +7 min

Read previewVice President Kamala Harris says she has a plan for America's middle class— building an "Opportunity Economy" to help them succeed. "Vice President Harris grew up in a middle class home as the daughter of a working mom. She believes that when the middle class is strong, America is strong," the Harris campaign wrote in a section titled "Build an Opportunity Economy and Lower Costs for Families." But just what exactly is Harris looking to do when she says she's going to build up the middle class through her "Opportunity Economy" agenda? During the debate, Harris accused Trump of only wanting to offer tax breaks to the richest people, while Trump countered by saying Harris lacked a detailed plan.

Persons: —, Kamala Harris, Harris, Donald Trump, she's, Biden, Trump, Alice Tecotzky, Goldman Sachs Organizations: Service, Business, Trump, American, Biden, Pharma, New York Times, Siena College Locations: America, North Carolina

☆ Mark Cuban is lauding Kamala Harris for joining him in his big fight to lower prescription drug prices
▼ + stars: | 2024-09-11 | by ( Kwan Wei Kevin Tan | ) www.businessinsider.com time to read: +1 min

Vice President Kamala Harris unveiled her policy platform on her campaign website on Sunday. Harris said she wants to lower drug prices "by taking on pharmacy middlemen." It appeared to cheer Mark Cuban, who's been taking on pharma companies with his own, Cost Plus Drugs. AdvertisementVice President Kamala Harris wants to lower drug prices, and billionaire investor Mark Cuban is all for it. The "Shark Tank" star then proceeded to quote part of Harris' policy position on drug prices in the same post.

Persons: Kamala Harris, Harris, Mark Cuban, who's, —, Joe Biden Organizations: pharma, Service, Democratic, Business

☆ Stocks making the biggest moves midday: GameStop, Viking Therapeutics, Trump Media and more
▼ + stars: | 2024-09-11 | by ( Lisa Kailai Han | ) www.cnbc.com time to read: +2 min

Trump Media & Technology — The stock fell more than 13% following Tuesday's debate between majority shareholder former President Donald Trump and Democratic Vice President Kamala Harris. Novartis — U.S.-listed shares of the Swiss pharma company slipped nearly 2% on the heels of Bank of America's downgrade to hold from buy. Crypto stocks — Crypto stocks were dragged downward after the price of bitcoin fell slightly overnight, as crypto traders considered central bank policy in Japan . Morgan Stanley — The bank stock lost 1% following a downgrade at Goldman Sachs to neutral from buy. Solar stocks — Solar stocks rose as a group after Vice President Kamala Harris's performance at Tuesday's debate raised confidence in a Democratic victory at the U.S. presidential election.

Persons: Donald Trump, Kamala Harris, Rentokil, it's, bitcoin, Morgan Stanley, Goldman Sachs, Goldman, Morgan, Warren Buffett's Berkshire Hathaway, Kamala Harris's, — CNBC's Sean Conlon, Michelle Fox, Alex Harring, Yun Li, Sarah Min, Samantha Subin Organizations: Trump Media & Technology, Democratic, Trump Media, Nasdaq, GameStop, Novartis — U.S, Swiss pharma, of, Therapeutics, JPMorgan, Viking Therapeutics, Goldman, Bank of America, U.S, Clean Energy, SolarEdge Technology, Sunnova Energy Locations: North America, Japan

New Hampshire voters will head to the polls Tuesday for a primary that will set up the matchup for one of just two governor’s races in presidential battleground states this year. In addition to North Carolina, New Hampshire is the only other swing state to hold a race for governor this election cycle. “I think that helps people in New Hampshire realize that Kelly Ayotte is a New Hampshire Republican, not a straight party loyalist,” Williams said. In New Hampshire, abortion is banned after fetal viability, or around the 24th week of pregnancy. “We’ve seen in the last few years that governors and state leadership sort of make or break it when it comes to protecting abortion rights,” Levy said.

Persons: Sen, Kelly Ayotte, Chuck Morse, Chris Sununu, Joyce Craig, Cinde Warmington, Amy Walter, Cook, Kamala Harris, Ayotte, Morse, Donald Trump, Trump, didn’t, hasn’t, Chuck Morse’s, he’s, Kelly, ”, Fergus Cullen, Cullen, Trumper, Sununu, Hillary Clinton, Joe Biden, “ She’s, Ryan Williams, “, ” Williams, “ Kelly, she’s, Maya Harvey, Chuck, ” Harvey, Craig, Jon Kiper, Warmington, Joyce Craig’s, Philip Stein, Kelly Ayotte’s, Joyce Craig's, ” Craig, Craig Brown, Craig “, “ It’s, Williams, They’ve, nodded, Neil Gorsuch, Gorsuch, Roe, Wade, Izzi Levy, “ We’ve, ” Levy, Dobbs, we’ve, Jason Osborne Organizations: New, Republican, GOP Gov, Democrats, Manchester, Hampshire, White, Democratic, GOP, New Hampshire Republicans, ” New, Republican Party, New Hampshire Republican, Purdue Pharma, Ayotte, Republicans, Hampshire Democrats, Trump, Democratic Governors Association Locations: New Hampshire, state’s, North Carolina , New Hampshire, Trump, Dover, ” New Hampshire, Manchester, Hampshire, New England, “ New Hampshire

☆ Want to cash in on India's growth? Veteran investor names 5 'well-run' companies to buy right now
▼ + stars: | 2024-09-10 | by ( Amala Balakrishner | In Amala-Balakrishner | ) www.cnbc.com time to read: +3 min

Interest in India has been rising steadily among investors, thanks to its growing economy , strong stock market performance and burgeoning population . Amid some talk of an Indian stock market bubble , however, Pramod Gubbi, co-founder of Marcellus Investment Managers, revealed how he is playing the market. So, our job is to evaluate whether the management teams are hungry enough to identify changes that are happening and adapt to them," he told CNBC Pro last week. Women-led themes One theme that Gubbi is interested in is how India's growing numbers of working women are spending their money. Other stocks Other Indian companies Gubbi likes include Divi's Laboratories and HDFC Bank .

Persons: Pramod Gubbi, Marcellus, Gubbi, Maggi, Nescafe Organizations: Marcellus Investment, Management, CNBC Pro, Bombay Stock Exchange, Tata Group, Brands, Nestle, —, Paints, Divi's Laboratories, HDFC Bank, Novartis, GSK, Merck Locations: India, U.S, China

☆ The Hard-Partying Lawyers Who Get Negligent Companies to Pay Billions
▼ + stars: | 2024-09-05 | by ( Jack Newsham | ) www.businessinsider.com time to read: +23 min

In 2023, mass-tort lawyers spent $152 million on TV ads and millions more on social media. The data provider X Ante estimated that in 2023, mass-tort lawyers spent $152 million on TV ads and millions more on social media. The decades that followed mass torts' onset on the national stage showed the big risks and big rewards of mass torts. AdvertisementIn a class action, a settlement is public, and the judge has to approve the lawyers' fees. But others are confident that indebted mass-tort lawyers can bounce back from a few bad bets.

Persons: Mike Papantonio, Pap, Johnson, Paul Cody, Bayer, Chris Seeger, audibles, Budd, Ness Motley, Motley Rice, South Carolina —, doling, Seeger, Wyeth, Phil Federico, Paul Hanly who'd, Federico, Lejeune, who've, Camp Lejeune, mack, Curt Miner, I've, Don Worley, Worley, —, Daniel A, Mark Lanier, wouldn't, Elizabeth Chamblee Burch, Burch, Ellen Relkin, Merck, Vioxx, There's, Lucian Pera, Keller Postman, Jeremy Troxel, Keller, Troxel, Michael McDonald, Warren Postman, Postman, Kelsey Vlamis, Jack Newsham Organizations: Wynn, Vegas, Camp Lejeune, pharma, Supreme, X, Pfizer, Defense, Marines, Veterans, Foreign, US Marine Corps, Johnson, University of Georgia, Business, Intuit, Rihanna, Morning Investments, Fortress Investment, Gramercy Funds, Deepwater, Investments Locations: Camp, Texas, South Carolina, Baltimore, North Carolina, Camp Lejeune, America, Beverly Hills , California, nonbanks

☆ Judge orders 'Pharma Bro' Martin Shkreli to hand over copies of one-of-a-kind Wu-Tang Clan album
▼ + stars: | 2024-08-26 | by ( Laura Italiano | ) www.businessinsider.com time to read: +1 min

"Pharma Bro" Martin Shkreli must surrender his Wu-Tang Clan album copies by Friday, a judge has ordered. The order is a victory for an NFT collective that bought the original "Once Upon a Time in Shaolin." The collective sued Shkreli after saying he boasted of sending copies to "chicks" and receiving sexual favors. AdvertisementA federal judge in Brooklyn has ordered "Pharma bro" Martin Shkreli to surrender all copies of his supposedly one-of-a-kind Wu-Tang Clan album by noon on Friday. The new preliminary order by Judge Pamela K. Chen, first reported in artnet, is the latest development in that lawsuit.

Persons: Bro, Martin Shkreli, Wu, Tang, Shkreli, —, bro, Pamela K, Chen Organizations: Service, PleasrDAO, Business Locations: Brooklyn, artnet

Several analysts raised their ratings and price targets on Starbucks a day after news that Chipotle CEO would take over at the coffee chain. Starbucks shares rallied on the news, while Chipotle shares fell. He also lowered his price target on shares to $685 from $750, which implies just 6% upside from Monday's close. Chipotle shares pulled back of 7% comes as decelerating trends and a sector rotation already impacted Chipotle's multiple. Since Niccol took the position of CEO in 2018, Chipotle shares surged more than 770%.

Persons: Bernstein, Fatima Boolani, Boolani, — Hakyung Kim, Eli Lilly Eli Lilly's, Berenberg, Lilly, Kerry Holford, " Holford, Morgan Stanley, Keith Weiss, Weiss, Hakyung Kim, Brian Niccol's, Danilo Gargiulo, Gargiulo, Niccol, Chipotle, Laxman Narasimhan, Brian Niccol, Baird, David Tarantino, Fred Imbert Organizations: CNBC, Citi, Palo Alto, Palo Alto Networks, pharma, Intuit, Starbucks, Deutsche Bank, SBUX Locations: Tuesday's

☆ Whoever can finally coin an effective economic message could win the White House
▼ + stars: | 2024-08-13 | by ( Stephen Collinson | ) edition.cnn.com time to read: +10 min

CNN —Voters keep telling pollsters that their economic insecurities are the biggest issue in the 2024 election. Former President Donald Trump will try to make a case against Kamala Harris’ role in the Biden economy on Wednesday in North Carolina. President Joe Biden dedicated his domestic agenda to restoring economic fairness and sought to revive manufacturing and repair the country’s crumbling infrastructure. As the effective incumbent in this race, Harris is vulnerable to any sudden shifts in the economic outlook. But with Trump seeking an opening to define her negatively — especially on the economy — Harris must act fast.

Persons: Donald Trump, Kamala Harris, Biden, Trump, Joe Biden, Harris, Kamala, He’s, Price, “, Biden Administration’s, ”, —, ” Harris, ” Trump, hasn’t, “ You’ve, Scott Jennings, Anderson Cooper, “ You’re, Brad Todd, CNN’s Kasie, he’s, ” Todd, Kevin McCarthy, Elon Musk, Sen, JD Vance, Harris ’, Bill Clinton, Barack Obama, Clinton, Obama, Obama –, –, — Harris, Tim Walz, She’s Organizations: CNN — Voters, Trump, Home Depot, Republican, Democratic, Biden, CNN, Fox News, Air Force, Democratic National Convention, NPR, PBS, Marist, New York Times, Siena College, Minnesota Gov, pharma Locations: North Carolina, Asheville , North Carolina, Maryland, Raleigh, Ohio, Chicago, Nevada, Phoenix, California, States, Pennsylvania, Michigan, Wisconsin

☆ More public healthcare companies will be taken private. Here's what PE firms are betting on.
▼ + stars: | 2024-08-12 | by ( Rebecca Torrence | ) www.businessinsider.com time to read: +7 min

Read previewRevenue cycle management company R1 RCM just announced its acquisition by two private equity firms for a whopping $8.9 billion — signaling a long-awaited resurgence of big healthcare deals. Private equity's return to the sceneThe debt market is finally correcting for the types of deals healthcare companies have been waiting for. Revenue cycle management has long been a hot area for private equity firms. AdvertisementSpringer said she thinks private equity firms are "very unlikely to buy a care delivery company in this environment." Sen. Markey introduced the Health Over Wealth Act in July that would limit private equity investment in healthcare providers.

Persons: —, Augmedix, Altaris, hasn't, dealmakers, David Marks, They're, Thad Davis, haven't, Davis, Tanay Tandon, Commure, Athelas, it's, Rebecca Springer, we'll, Shiv Rao, Abridge Springer, she'd, Springer, Steward, Sen, Markey, Brian Snyder, Knight's Marks, I've, Marks Organizations: Service, Business, Holland &, Leerink Partners, Epic, Mayo Clinic, Reuters, Holland, FTC

☆ Stocks making the biggest premarket moves: KeyCorp, Starbucks, JetBlue, Eli Lilly and more
▼ + stars: | 2024-08-12 | by ( Michelle Fox | ) www.cnbc.com time to read: +2 min

Check out the companies making the biggest moves in premarket trading: KeyCorp — Shares of the Cleveland-based regional bank jumped 18% after the announcement of a minority investment from The Bank of Nova Scotia. The deal gives Scotiabank 14.9% of KeyCorp's common stock for roughly $2.8 billion in cash. Eli Lilly — The pharma stock added 1.4% following an upgrade at Deutsche Bank to buy from hold. The bank cited Eli Lilly's recent earnings beat and called the stock a "low beta/high growth" unicorn. JetBlue Airways — Shares tumbled nearly 6% after the airline announced plans to offer $400 million of convertible senior notes due in 2029.

Persons: Eli Lilly, Eli Lilly's, Robinhood, Piper Sandler, Fred Imbert, Jesse Pound, Sarah Min, Pia Singh Organizations: The Bank of, Scotiabank, Starbucks, Street Journal, pharma, Deutsche Bank, JetBlue Airways, Hawaiian Electric Industries, Maui, Qualcomm, Wolfe Research, Apple Locations: Cleveland, The Bank of Nova Scotia

☆ Goldman sees nothing 'sinister' ahead like past times market volatility reached these kinds of levels
▼ + stars: | 2024-08-09 | by ( Fred Imbert | ) www.cnbc.com time to read: +2 min

Global markets reached levels of turbulence rarely seen this week, but traders at Goldman Sachs are unfazed and don't believe it is a sign of a big danger lurking. The S & P 500 and Dow Jones Industrial Average on Monday suffered their biggest one-day declines since 2022. The market then roared back with the S & P 500 posting its biggest gain since 2022 on Thursday. After the late-week comeback, the S & P 500 is only down for the week by about half a percent. .VIX 5D bar Wild week for VIX Goldman traders expect gains going forward, but they see the path higher as a "choppy" one.

Persons: Goldman Sachs, Wall Street's, Goldman, VIX Goldman, Morgan Stanley, Eli Lilly, LLY Organizations: Goldman, Dow Jones, Monday, JPMorgan, pharma

☆ These high-dividend-yielding stocks could see a rebound as rates decline, BMO says
▼ + stars: | 2024-08-07 | by ( Michelle Fox | ) www.cnbc.com time to read: +4 min

Now could be a good time to start buying stocks with high dividend yields, according to BMO Capital Markets. The highest-paying S & P 500 stocks have significantly underperformed the index over the last year and a half, even with the rebound they've enjoyed in recent months, said chief investment strategist Brian Belski. They are rated outperform by the firm's analysts and fall within the top 25% of S & P 500 stocks by dividend yield. Digital Realty Trust, which pays a 3.28% dividend yield, owns, develops and operates data centers — which are expected to see surging demand thanks to AI . Host Hotel & Resorts, which owns luxury and upper-upscale hotels, has a 4.92% dividend yield and is down 16% so far this year.

Persons: they've, Brian Belski, Belski, AbbVie Organizations: BMO Capital Markets, Federal, Fed, BMO, Pfizer, pharma, AbbVie, Cerevel Therapeutics, American Electric Power, Southern Company, Utilities, Digital Realty Trust, Host Hotels, Resorts Locations: Southern

☆ 3 election-proof trades to boost your portfolio regardless of a Harris or Trump win
▼ + stars: | 2024-08-04 | by ( Christine Ji | ) www.businessinsider.com time to read: +5 min

Amid the backdrop of the US' polarized political environment, it might seem like the differences between Harris and Trump are night and day. DWS Group identified the following three areas of the market that'll perform well under a Trump or Harris presidency. Big Tech and AI aren't going anywhere this November, according to DWS Americas Chief Investment Officer David Bianco. If Trump wins, tax cuts will provide a boost to corporate America and increase consumer spending. If Harris wins, the dollar will strengthen for different reasons.

Persons: —, Harris, Trump, David Bianco, Bianco, Amanda Rebello, DWS, Frank Kelly, Biden, Kelly, Russell Organizations: Service, Trump, Big Pharma, DWS, Business, Big Tech, Republicans, Vanguard Utilities, International Stock ETF Locations: America

☆ Earnings playbook: Disney and this industrial giant are among companies slated to report this week
▼ + stars: | 2024-08-04 | by ( Fred Imbert | ) www.cnbc.com time to read: +4 min

More than 70 S & P 500 names are slated to report this week, including Disney and Caterpillar . Tuesday Uber Technologies is set to report earnings before the bell. This quarter: The ride-hailing giant is expected to report a 70% year-over-year increase in earnings, LSEG data shows. What history shows: Uber has beaten earnings expectations in six of the last seven quarters, according to data from Bespoke Investment Group. Wednesday Walt Disney is set to report earnings before the open.

Persons: Eli Lilly, Benjamin Black, Uber, Walt Disney, Wells, Steven Cahall, LLY, Eli Lilly's Organizations: Disney, Caterpillar . Pharmaceutical, behemoth, CNBC, Technologies, Investors, Autonomous Vehicle, Deutsche Bank, Investment, Caterpillar, JPMorgan Locations: California

☆ Insider Today: Mark Cuban vs. Big Pharma
▼ + stars: | 2024-08-04 | by ( Dan Defrancesco | ) www.businessinsider.com time to read: +5 min

But first: Big Tech reporting for duty. AdvertisementEven before Amazon, Apple, Meta, and Microsoft reported earnings, investors' focus was clear. Meta CEO Mark Zuckerberg didn't shy away from his intention to keep plowing money into AI, but investors didn't mind. Softening demand from shoppers for Amazon led to a miss in reported net sales and a weaker-than-expected sales forecast for the third quarter. Also read:Getty Images; Jenny Chang-Rodriguez/BIMark Cuban's pharma missionIn 2022, Mark Cuban launched a low-cost online pharmacy with the goal of cutting drug prices for consumers.

Persons: —, Jeff Bottari, Rebecca Zisser, Tesla, Mark Zuckerberg, iStock, That's, Gen, Zers, Tyler Le, Tetiana Lazunova, Jenny Chang, Rodriguez, Cuban's, Mark Cuban, somebody's, Emily Durham Organizations: Service, Business, Big Tech, Getty Images, Apple, Meta, Microsoft, Apple Intelligence, Amazon, pharma, Cuban's pharma, Cost, Pfizer, Novo Nordisk Locations: China

☆ Tesla's unique approach to sales is giving it headaches
▼ + stars: | 2024-08-02 | by ( Dan Defrancesco | ) www.businessinsider.com time to read: +6 min

The big storyFor saleGetty Images; Jenny Chang-Rodriguez/BIOne of Tesla's biggest assets is its willingness to try new things, but its unique approach to sales is also what's giving it headaches. AdvertisementA key issue is Tesla's inability to evolve its sales tactics as the EV market rapidly changes . Business Insider's Grace Kay spoke to more than a dozen current and former employees in Tesla's sales division about how the company has tried to kick-start its sales unit . Not unlike its cars, Tesla's sales approach is innovative compared to the rest of the automotive industry. It's a great strategy when the cars sell themselves — which Teslas did for a while — since you don't need to maintain a traditional sales structure.

Persons: —, Jenny Chang, Rodriguez, It's, Elon Musk, Insider's Grace Kay, There's, Teslas, Justin Sullivan, Fintechs, chatbots, Rebecca Zisser, Goldman Sachs, James Knightley, Andy Jassy, Mike Blake, Chelsea Jia Feng, Venu, Dan DeFrancesco, Jordan Parker Erb, Hallam Bullock, Annie Smith, Amanda Yen Organizations: Service, Business, EV, Tech, Citadel, ING Economics, Big Pharma, Pfizer, Novo Nordisk, Department of Labor, Chevron, ExxonMobil Locations: New York, London

☆ The GenAI jitters: Is there enough demand for $1 trillion in AI spending?
▼ + stars: | 2024-08-02 | by ( Alistair Barr | Eugene Kim | ) www.businessinsider.com time to read: +4 min

AdvertisementBig tech companies are forecast to spend $1 trillion on data centers, real estate, chips and other gear to build AI models, tools and products. AdvertisementSome big tech companies have already whittled away a large chunk of their cash reserves chasing this AI trend. For more than a year, the assumption has been that generative AI will stoke a massive wave of new demand. What if that demand turns out to be weaker than expected? A major piece of evidence he shared was about demand for Microsoft's 365 Copilot service.

Persons: —, Ashley Stewart, I've, Ashley, Keith Weiss, Morgan Stanley, Weiss, Andy Jassy, Sundar Pichai, Satya Nadella, BI's Ashley Stewart, Nadella Organizations: Service, Business, pharma, Big, Microsoft, stoke, Amazon, Google, CIO

☆ CNBC's Inside India newsletter: Can India's hot deal-making season extend to a free trade agreement?
▼ + stars: | 2024-08-01 | by ( Ganesh Rao | ) www.cnbc.com time to read: +3 min

Customers browse the S1 Pro electric scooter of Ola Electric Mobility Pvt. SoftBank -backed Ola Electric is set to raise nearly three quarters of a billion dollars with a stock market listing. India and four European nations — Iceland, Liechtenstein, Norway and Switzerland — struck a free trade agreement (FTA) earlier this year. "Our Free Trade Agreement negotiations is the floor not the ceiling of our ambitions to unlock our shared potential and deliver growth, from Bengaluru to Birmingham," Lammy said last week before his visit. India and the U.K. also have high rankings on the World Bank's Trade Complementarity Index, which indicates whether countries are natural trade partners.

Persons: Ola, Samyukta Lakshmi, Bharat, Switzerland —, David Lammy, Lammy, Chietigj Bajpaee, Narendra Modi's, Aastha Gudwani, Murugesh Organizations: Ola Electric Mobility, Ola Experience, Ola, Bloomberg, Getty, Mankind, Vaccines, South, House, India, Indian, Bank of America's, NYSE Locations: Bengaluru, India, Iceland, Liechtenstein, Norway, Switzerland, New Delhi, Birmingham, South Asia, Bank of America's India, Singapore, Japan

☆ We asked Mark Cuban how he's going to disrupt Big Pharma. He said it's pretty straightforward, actually.
▼ + stars: | 2024-08-01 | by ( Hilary Brueck | ) www.businessinsider.com time to read: +5 min

Here's how it works: Cost Plus Drugs, as the name implies, gets drugs directly from manufacturers, cutting out the pharmaceutical middlemen and their extra costs. You pay a 15% markup to Cost Plus Drugs, plus a fixed $5 for labor on each medication and $5 for shipping. How much will a name-brand, 30-day supply of the biggest dose of the "little blue pill" (100mg) cost you? A generic form of the same 30-day supply might start somewhere around $250, but can also exceed $1,000. AdvertisementCost Plus tells consumers that it pays the manufacturer $3 for that same 30-day supply of 100mg generic Viagra tablets.

Persons: —, Cuban, Abraham Gonzalez Fernandez, unbranded, isn't, who've, they've Organizations: Service, Big Pharma, Cuban, Plus, Business, Shark, Dallas Mavericks, Pfizer, Novo Nordisk, US Food and Drug Administration Locations: Texas

☆ Watch CNBC's full interview with Teva Pharma CEO Richard Francis
▼ + stars: | 2024-07-31 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailWatch CNBC's full interview with Teva Pharma CEO Richard FrancisRichard Francis, Teva Pharma CEO, joins 'Money Movers' to discuss how much of the company's momentum is around its generic obesity drug, outlooks on the company's earnings, and much more.

Persons: Richard Francis Richard Francis Organizations: Teva Pharma

☆ Teva Pharma CEO: Majority of momentum came from innovative business, not GLP-1s
▼ + stars: | 2024-07-31 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailTeva Pharma CEO: Majority of momentum came from innovative business, not GLP-1sRichard Francis, Teva Pharma CEO, joins 'Money Movers' to discuss how much of the company's momentum is around its generic obesity drug, the market's excitement around its GLP-1 drug, and much more.

Persons: Richard Francis Organizations: Teva, Teva Pharma

☆ Sanofi CEO Paul Hudson: We have one of the best growth profiles in all of Big Pharma
▼ + stars: | 2024-07-31 | by ( ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailSanofi CEO Paul Hudson: We have one of the best growth profiles in all of Big PharmaSanofi CEO Paul Hudson joins 'Squawk Box' to discuss the company's record demand for Dupixent, state of drug innovation in Europe, company outlook, and more.

Persons: Paul Hudson Organizations: Sanofi, Big Pharma Sanofi Locations: Europe

☆ 4 areas of the market set to surge if Trump wins the election — and 3 poised to benefit from a Harris victory
▼ + stars: | 2024-07-31 | by ( Christine Ji | ) www.businessinsider.com time to read: +7 min

When it comes to investing in sectors such as financials and energy under Trump, Bianco believes that size matters. A Harris presidency would benefit the renewable energy industry, according to Amanda Rebello, head of Xtrackers ETF sales at DWS. That's primarily because a Harris presidency would result in more stringent fiscal policy than a Trump one. The national debt is also likely to rise faster under a Trump presidency compared to a Harris one. AdvertisementInvestors can prepare for a Harris presidency by adding fixed income assets such as US 10-year Treasury notes to their portfolios.

Persons: —, David Bianco, Harris, it's, He's, Bianco, Trump, Russell, REITs There's, Amanda Rebello, That's, he's, REITs, iShares Cohen Organizations: Service, Trump, Business, Republican, DWS Group, Republican National Convention, Big Pharma, VanEck Pharmaceutical, Vanguard, Energy, Democratic, Fed, Harris, Real, Investment, Battery Tech, Clean Energy, Schwab, Steers, ETF Locations: Big, Harris ' California

☆ A CIO cancelled a Microsoft AI deal. The reason why should worry the entire tech industry.
▼ + stars: | 2024-07-31 | by ( Ashley Stewart | ) www.businessinsider.com time to read: +1 min

A pharmaceutical company stopped using Microsoft's Copilot AI tool due to high cost and low value. The company used Office 365 Copilot for 500 staff, and found it comparable to middle school presentations. Microsoft is considering repackaging 365 licenses to better monetize AI features amid record capex. That's exactly what happened when an IT executive at a pharmaceutical company tried out Microsoft's Copilot AI features. The chief information officer of this pharma company paid extra to have 500 employees use Office 365 Copilot in the fourth quarter of 2023 and first quarter of 2024.

Persons: — Organizations: Microsoft, Service, pharma, Business

Search resuls for: "PHARMA"

25 mentions found